Cas:536721-25-2 N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester manufacturer & supplier

We serve Chemical Name:N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester CAS:536721-25-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester

Chemical Name:N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester
CAS.NO:536721-25-2
Synonyms:1-({(2S)-4-Carboxylato-1-[(2-methyl-2-propanyl)oxy]-1-oxo-2-butanyl}amino)-1-oxohexadecane;L-Glutamic acid, N-(1-oxohexadecyl)-, 1-(1,1-dimethylethyl) ester, ion(1-);N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester
Molecular Formula:C25H46NO5
Molecular Weight:440.637
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:591.0±40.0 °C at 760 mmHg
Density:N/A
Index of Refraction:
PSA:99.02000
Exact Mass:440.338135
LogP:7.55

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-({(2S)-4-Carboxylato-1-[(2-methyl-2-propanyl)oxy]-1-oxo-2-butanyl}amino)-1-oxohexadecane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,L-Glutamic acid, N-(1-oxohexadecyl)-, 1-(1,1-dimethylethyl) ester, ion(1-) Use and application,1-({(2S)-4-Carboxylato-1-[(2-methyl-2-propanyl)oxy]-1-oxo-2-butanyl}amino)-1-oxohexadecane technical grade,usp/ep/jp grade.


Related News: The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester manufacturer The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester supplier The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion. N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester vendor Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies. N-(1-Oxohexadecyl)-L-glutaMic Acid tert-Butyl Ester factory The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.